Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jan;19(1):204–211. doi: 10.1128/iai.19.1.204-211.1978

Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes.

R J Ulevitch, C G Cochrane
PMCID: PMC414068  PMID: 24001

Abstract

The effect of C3 depletion on the multiple pathophysiological changes produced by a lethal dose of Serratia marcescens lipopolysaccharide (LPS) was evaluated. The injection of this LPS into rabbits resulted in biphasic hypotensive changes and thrombocytopenia. These changes were characterized by an acute, transient decrease occurring within minutes after injection followed by a second more gradual decrease beginning 30 to 60 min post-LPS. Prior depletion of C3, with the anticomplementary protein from cobra venom (CoF), did not alter the extent of either the gradual hypotensive and platelet changes or the coagulative and metabolic changes when normal and C3-depleted rabbits were compared. Importantly, the lethal effects of S. marcescens LPS were not reduced by prior depletion of C3. Only the immediate, reversible thrombocytopenia and hypotension were abrogated by C3 depletion.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back U., Moller B. B., Bog-Hansen T. C. Host resistance to lipopolysaccharides in the pathogenesis of multiple sclerosis and membranoproliferative glomerulonephritis. Lancet. 1976 Jul 24;2(7978):188–192. doi: 10.1016/s0140-6736(76)92358-8. [DOI] [PubMed] [Google Scholar]
  2. Ballow M., Cochrane C. G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969 Nov;103(5):944–952. [PubMed] [Google Scholar]
  3. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown D. L., Lachmann P. J. The behaviour of complement and platelets in lethal endotoxin shock in rabbits. Int Arch Allergy Appl Immunol. 1973;45(1):193–205. doi: 10.1159/000231028. [DOI] [PubMed] [Google Scholar]
  5. CHEDID L., SKARNES R. C., PARANT M. Characterization of a Cr51-labeled endotoxin and its identification in plasma and urine after parenteral administration. J Exp Med. 1963 Apr 1;117:561–571. doi: 10.1084/jem.117.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. From A. H., Gewurz H., Gruninger R. P., Pickering R. J., Spink W. W. Complement in endotoxin shock: effect of complement depletion on the early hypotensive phase. Infect Immun. 1970 Jul;2(1):38–41. doi: 10.1128/iai.2.1.38-41.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GILBERT V. E., BRAUDE A. I. Reduction of serum complement in rabbits after injection of endotoxin. J Exp Med. 1962 Oct 1;116:477–490. doi: 10.1084/jem.116.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garner R., Chater B. V., Brown D. L. The role of complement in endotoxin shock and disseminated intravascular coagulation: experimental observations in the dog. Br J Haematol. 1974 Nov;28(3):393–401. doi: 10.1111/j.1365-2141.1974.tb00820.x. [DOI] [PubMed] [Google Scholar]
  9. Griffin J. H., Cochrane C. G. Human factor XII (Hageman factor). Methods Enzymol. 1976;45:56–65. doi: 10.1016/s0076-6879(76)45009-7. [DOI] [PubMed] [Google Scholar]
  10. HEIFFER M. H., MUNDY R. L., MEHLMAN B. Effect of lethal doses of bacterial endotoxin (E. coli) on sympathetic neurohormones in the rabbit. Am J Physiol. 1960 Jun;198:1307–1311. doi: 10.1152/ajplegacy.1960.198.6.1307. [DOI] [PubMed] [Google Scholar]
  11. Henson P. M. Complement-dependent platelet and polymorphonuclear leukocyte reactions. Transplant Proc. 1974 Mar;6(1):27–31. [PubMed] [Google Scholar]
  12. Kitzmiller J. L., Lucas W. E., Yelenosky P. F. The role of complement in feline endotoxin shock. Am J Obstet Gynecol. 1972 Feb 1;112(3):414–421. doi: 10.1016/0002-9378(72)90488-7. [DOI] [PubMed] [Google Scholar]
  13. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  15. Skarnes R. C. In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity. J Bacteriol. 1968 Jun;95(6):2031–2034. doi: 10.1128/jb.95.6.2031-2034.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ulevitch R. J., Cochrane C. G. Complement-dependent hemodynamic and hematologic changes in the rabbit. Inflammation. 1977 Sep;2(3):199–216. doi: 10.1007/BF00917596. [DOI] [PubMed] [Google Scholar]
  17. Ulevitch R. J., Cochrane C. G., Henson P. M., Morrison D. C., Doe W. F. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med. 1975 Dec 1;142(6):1570–1590. doi: 10.1084/jem.142.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ulevitch R. J., Morrison D. C., Cochrane C. G., Henson P. M. Complement independent lipopolysaccharide (LPS) induced hypotension and disseminated intravascular coagulation: a correlation of LPS structure with in vivo and in vitro biological activities. Adv Exp Med Biol. 1976;73(PT-A):339–349. doi: 10.1007/978-1-4684-3297-8_28. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES